awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33399582-19153630-701C-44E1-B142-82131BA8E947
Q33399582-19153630-701C-44E1-B142-82131BA8E947
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33399582-19153630-701C-44E1-B142-82131BA8E947
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.
P2860
Q33399582-19153630-701C-44E1-B142-82131BA8E947
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33399582-19153630-701C-44E1-B142-82131BA8E947
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ca1640f50e6d22757b04e85cf1b654e1b9cf3c4
P2860
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK).